Acknowledgement to Referees: Acknowledgement to Referees: Acknowledgement to Referees.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 1, doi. 10.1007/s40259-024-00697-8
- Publication type:
- Article
Works matching IS 11738804 AND DT 2025 AND VI 39 AND IP 1
Results: 12
1
2
Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective: Sequelae of B-Cell Depleting Therapy: M. Kacar et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
3
Correction: Monoclonal Antibody Generation Using Single B Cell Screening for Treating Infectious Diseases: Therapeutic mAb Generation Using Single B Cell Screening: J.S. Schardt et al.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
4
Investigational RNA Interference Agents for Hepatitis B: RNA Interference Agents in Hepatitis B: R. W.-H. Hui et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 21, doi. 10.1007/s40259-024-00694-x
- By:
- Publication type:
- Article
5
Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review: Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches: S. Szwec et al.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
6
CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?: CAR T Cells in Rheumatic Diseases: Future Prospects: J. Avouac et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 5, doi. 10.1007/s40259-024-00692-z
- By:
- Publication type:
- Article
7
The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds: Growing and Emerging Applications of Bispecific Antibodies: D. A. Ellerman.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 75, doi. 10.1007/s40259-024-00691-0
- By:
- Publication type:
- Article
8
Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease: Relevance of ADAs in Pegunigalsidase Alfa-Treated Patients: M. Lenders et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 153, doi. 10.1007/s40259-024-00690-1
- By:
- Publication type:
- Article
9
Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study: Biological Therapy for Psoriasis and the Risk of Psoriatic Arthritis: Y. Cho et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 143, doi. 10.1007/s40259-024-00689-8
- By:
- Publication type:
- Article
10
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors: Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors: K. Mestermann et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
11
Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa: Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa: G. P. Salgueiro et al.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
12
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness: Comparative Analysis of Trastuzumab Originator and Biosimilars: T. Mamori et al.
- Published in:
- BioDrugs, 2025, v. 39, n. 1, p. 131, doi. 10.1007/s40259-024-00686-x
- By:
- Publication type:
- Article